Is it too late to buy Ramsay Health Care Limited shares?

Over the last 30 days the Ramsay Health Care Limited (ASX: RHC) share price has been amongst the better performers on the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO).

During this time the private hospital operator’s shares have climbed almost 9% higher, compared to the market’s 4% gain.

Is it too late to invest?

I don’t believe for a second that it is too late to snap up shares if you are prepared to make a buy and hold investment.

Despite the strong gain it has made this month, Ramsay’s shares are still down over 11% from their 52-week high.

Furthermore, they are changing hands at 28x trailing earnings. I believe this is reasonable for a company with defensive earnings, a market-leading position, and strong long-term growth prospects thanks to ageing populations and increased chronic disease burden.

Ramsay also has the possibility of accelerating its earnings growth through brownfield and greenfield expansions and acquisitions.

One country which Ramsay is yet to have a presence in is China. It pulled out of a joint venture in the country last year, but continues to talk up the opportunity.

I expect that within the next few years we will see Ramsay enter the lucrative China market, potentially giving its bottom line a significant boost.

In light of this, I believe that Ramsay is a great investment option and I would recommend it ahead of industry rivals Primary Health Care Limited (ASX: PRY) and Healthscope Ltd (ASX: HSO).

As well as Ramsay, I think these top growth shares would be great buy and hold investments.

Top 3 ASX Blue Chips To Buy In 2017

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2017."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.